Covid: Screening Europe to identify investment opportunities by relative resilience
In this strategy product covering 36 pages, we screen the combined AlphaValue & Baader...
2020 earnings: -25% and falling
AlphaValue's analysts rushed the earnings-cut exercise as businesses dislocate worldwide wit...
Sonova's hearing eclipsed
When we last teased about Sonova in September 2018, the world’s No.1 hearing aids manufacturer...
From NIG to virused zombies
We count 77 stocks which are non-investment grades in the AlphaVaue coverage, excluding financi...
China & ESG, an oxymoron
Following is AlphaValuetake regarding what Covid-19 reveals about currentCorporate Social Respo...
Will banks behave?
Who will be lending? It was clear from late January that the Coronavirus-induced mess was a supply...